Background: The diagnostic performance of numerous clinical specimens to diagnose
COVID-19 through RT-PCR techniques is very important, and the test result outcome is still …

Background Diagnosis is one of the main strategies to deal with infectious and deadly
diseases such as coronavirus disease 2019 (COVID‐19). The global pandemic of COVID …

From early 2020, a high demand for SARS-CoV-2 tests was driven by several testing
indications, including asymptomatic cases, resulting in the massive roll-out of PCR assays to …

Approximately 6% of those with COVID‐19 will experience cutaneous manifestations.
Examining data from this cohort could provide useful information to help with the …

Purpose: During the COVID-19 pandemic, the use of salivary swabs (SS) to detect the SARS-
CoV-2 virus has been implemented and widely studied in adults and children. However, the …

Abstract We compared ID Now™ and Hologic® Panther Aptima™ for the detection of SARS-
COV-2. ID Now™ showed a positive and negative percent agreement of 86.9% and 99.7 …

Abstract Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-
2 virus. Most people infected with the virus will experience mild to moderate respiratory …

During the multiple waves of COVID-19 suffered all over the world, having a rapid and
sensitive diagnostic test has become a priority for microbiology laboratories. The AptimaTM …

Faced with the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), high-throughput respiratory tests are in high demand. We evaluated the clinical …

The rapid scale-up of testing capacity in combination with a testing strategy linked to contact
tracing, including intense screening of asymptomatic persons, resulted in the massive roll …